PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|34|5590-5606

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.34, 2012-11, pp. : 5590-5606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Urologic Malignancies

By Moffat Leslie E.  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 105-105

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Treatment for Erectile Dysfunction Based on Patient-Reported Outcomes: To Every Man the PDE5 Inhibitor that He Finds Superior

By Hedelin Hans   Ströberg Peter  

Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. : 2245-2251

Adis International

Access to resources Recommend Favorite

PDE5 Inhibitors in the Treatment of LUTS

By  

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3502-3505

Bentham Science Publishers

Access to resources Recommend Favorite

Antibiotic Prophylaxis in Urologic Prosthetic Surgery

By  

Current Pharmaceutical Design, Vol. 9, Iss. 12, 2003-05 ,pp. : 989-996

Bentham Science Publishers

Access to resources Recommend Favorite

PDE5 Inhibitors in Non-Urological Conditions

By  

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3521-3539

Bentham Science Publishers

Access to resources Recommend Favorite